Helicobacter pylori eradication in children

Comparative study of efficacy of dual therapy with amoxicillin/omeprazole to the standard triple therapy in eradication of Helicobacter pylori infection in children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201807134057681

Enrollment

156

Registered

2018-07-26

Start date

2018-08-01

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Helicobacter pylori gastritis Paediatrics

Interventions

Dual therapy

Triple therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Endoscopic biopsy based diagnosis of H. pylori gastritis in patients having upper gastrointestinal symptoms suggestive of peptic ulcer disease.

Exclusion criteria

Exclusion criteria: Previous treatment with antisecretory, antimicrobial or anti-inflammatory medication, for 3 weeks preceding the endoscopy. History of drug allergy to any of medications used in the study. Presence of any concurrent illness that prevents intake of medication.

Design outcomes

Primary

Measure	Time frame
Eradication of H. pylori (by H. pylori stool antigen test)	—

Secondary

Measure	Time frame
Adverse effects of therapy(headache, upper respiratory tract infection, diarrhea, nausea and abdominal discomfort) ;Compliance	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 18, 2026